Persist AI Analysis: $4M Raised
What is Persist AI?
Persist AI specializes in next-generation formulation development processes that leverage robotics and artificial intelligence. Their unique approach utilizes high throughput screening to accelerate drug product development, particularly for long-acting injectables and amorphous solid dispersions. This innovation significantly reduces the time and cost associated with bringing drug formulations to market.
Employees
51-200
Founded
2022
Industry
HealthTech, Robotics, Biotech
Product Features & Capabilities
- Cloud Lab for automated formulation experiments
- Formulation development using AI and robotics
- Commercial cGMP manufacturing for clinical batches
- Analytical support with extensive capabilities
- High throughput screening for rapid formulation discovery.
Use Cases
Accelerate drug formulation development using AI-driven insights; Optimize formulation processes with robotic automation; Conduct high throughput screening for drug products; Implement commercial manufacturing for clinical trials; Analyze complex formulation data sets efficiently.
How much Persist AI raised
Seed - $4 million
August 16, 2024Lead Investor: Not specified in the available information.
Other Considerations
Raised over $12M in funding; Collaborates with OSD Pharmaceuticals Solutions Inc.; Focuses on AI-driven pharmaceutical development.
See something that needs updating? Suggest edits to this profile.
